CA2600384A1 - Compositions et procede de traitement de l'acne - Google Patents

Compositions et procede de traitement de l'acne Download PDF

Info

Publication number
CA2600384A1
CA2600384A1 CA002600384A CA2600384A CA2600384A1 CA 2600384 A1 CA2600384 A1 CA 2600384A1 CA 002600384 A CA002600384 A CA 002600384A CA 2600384 A CA2600384 A CA 2600384A CA 2600384 A1 CA2600384 A1 CA 2600384A1
Authority
CA
Canada
Prior art keywords
acne
extract
skin
agent
vasoconstrictor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002600384A
Other languages
English (en)
Other versions
CA2600384C (fr
Inventor
Jacob M. Waugh
Jae Hoon Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revance Therapeuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2600384A1 publication Critical patent/CA2600384A1/fr
Application granted granted Critical
Publication of CA2600384C publication Critical patent/CA2600384C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention porte sur des trousses anti-acné qui sont utilisées pour traiter l'acné, en particulier les cas sévères d'acné. Les trousses anti-acné de l'invention comprennent un vasoconstricteur et un agent anti-acné et, facultativement, un agent thérapeutique éclaircissant la peau et/ou une couche d'étanchéité et/ou un agent nettoyant la peau et/ou un astringent et/ou un agent facilitant la pénétration cutanée et/ou un écran solaire et/ou des compléments nutritifs qui favorisent la cicatrisation des lésions d'acné. L'invention se rapporte également à des procédés permettant de traiter l'acné au moyen d'un vasoconstricteur conjugué à un agent anti-acné.
CA2600384A 2005-03-30 2006-03-30 Compositions et procede de traitement de l'acne Expired - Lifetime CA2600384C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66653105P 2005-03-30 2005-03-30
US60/666,531 2005-03-30
PCT/US2006/012095 WO2006105450A2 (fr) 2005-03-30 2006-03-30 Compositions et procede de traitement de l'acne

Publications (2)

Publication Number Publication Date
CA2600384A1 true CA2600384A1 (fr) 2006-10-05
CA2600384C CA2600384C (fr) 2016-08-30

Family

ID=37054204

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2600384A Expired - Lifetime CA2600384C (fr) 2005-03-30 2006-03-30 Compositions et procede de traitement de l'acne

Country Status (9)

Country Link
US (2) US8580317B2 (fr)
EP (1) EP1863507A4 (fr)
JP (2) JP5388568B2 (fr)
KR (1) KR20080006568A (fr)
BR (1) BRPI0608951A2 (fr)
CA (1) CA2600384C (fr)
IL (1) IL185540A0 (fr)
MX (1) MX2007012101A (fr)
WO (1) WO2006105450A2 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
JP5388568B2 (ja) * 2005-03-30 2014-01-15 ルバンス セラピュティックス インク． ざ瘡を治療するための組成物及び方法
US20080226568A1 (en) * 2007-03-13 2008-09-18 Playtex Products, Inc. Synergistic preservative systems and their use in topical compositions
CA2694046C (fr) 2007-07-26 2023-09-12 Revance Therapeutics, Inc. Peptides cationiques et compositions de ceux-ci
CN101827579B (zh) * 2007-10-17 2013-01-23 生物关怀有限公司 木酚素系化合物或含有该化合物的肉豆蔻提取物或肉豆蔻假种皮提取物的新用途
PL2209458T3 (pl) * 2007-11-14 2019-01-31 Obagi Cosmeceuticals Llc Kompozycje do traktowania skóry
US8114898B2 (en) 2007-11-16 2012-02-14 Allergan, Inc. Compositions and methods for treating purpura
US7785638B2 (en) * 2008-02-28 2010-08-31 Himalaya Global Holdings, Ltd Herbal acne control composition, method of manufacturing the same and use thereof
MX2011005010A (es) * 2009-01-05 2011-05-30 Sol Gel Technologies Ltd Composiciones topicas que contienen agentes activos recubiertos.
JP2010222317A (ja) * 2009-03-25 2010-10-07 Shiseido Co Ltd 水中油型乳化化粧料
DE112009005041T5 (de) * 2009-07-08 2012-09-27 Joben Bio-Medical Co., Ltd. Verfahren der Extraktzubereitung aus Longankern und die Anwendung des Longankernextrakts
CN102573787A (zh) 2009-08-14 2012-07-11 株式会社爱茉莉太平洋 含有天然提取物的组合物
KR101693694B1 (ko) * 2009-08-31 2017-01-09 (주)아모레퍼시픽 옹기중탕을 이용한 약재의 피부재생효능 증진방법
US9180112B2 (en) * 2010-03-23 2015-11-10 Ermis Labs, LLC Dermal compositions containing gorgonian extract
US8309143B2 (en) 2010-04-16 2012-11-13 Doreen Campbell Hair and scalp care formulations for treating and preventing acne and related skin conditions
KR101739129B1 (ko) * 2010-10-05 2017-05-23 쓰리엠 이노베이티브 프로퍼티즈 캄파니 알레르겐 불활성화제
WO2012092389A2 (fr) 2010-12-28 2012-07-05 Mary Kay Inc. Composition de régulation du sébum et anti-acné
CN106176361A (zh) 2010-12-30 2016-12-07 玫琳凯有限公司 局部皮肤用组合物及其用途
JP6225030B2 (ja) * 2011-02-15 2017-11-01 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
MX370929B (es) 2012-10-28 2020-01-08 Revance Therapeutics Inc Composiciones y usos de las mismas para el tratamiento seguro de la rinitis.
CN103006681B (zh) * 2012-12-04 2014-07-09 哈尔滨乐泰药业有限公司 治疗痤疮的复方乳膏及其制备方法
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
US9980998B2 (en) * 2015-10-07 2018-05-29 Braerg—Grupo Barśileiro De Pesquisas Especializadas Ltda. Medicinal composition having antibiotic, anti-inflammatory, and wound healing activity
EP3458099A4 (fr) 2016-05-18 2020-07-22 Dermala Inc. Compositions et procédés de traitement de l'acné vulgaire
US10596090B2 (en) * 2016-05-27 2020-03-24 Jan Marini Skin Research Cosmetic formulation to reduce facial flushing
WO2019046311A1 (fr) 2017-08-28 2019-03-07 Revance Therapeutics, Inc. Compositions transmucosales de toxine botulique, kits et procédés de traitement de troubles de la vessie
AU2019249392B2 (en) * 2018-04-03 2022-10-20 Sami Labs Limited Skin care compositions and their applications
EP3873508A4 (fr) * 2018-11-01 2022-05-18 Yeditepe Universitesi Médicament pour le traitement du psoriasis et son procédé de production
AU2019384569B2 (en) * 2018-11-21 2025-07-31 Products On The Go, LLC Certified natural skin care products
KR102170850B1 (ko) * 2020-06-26 2020-11-02 박시헌 여드름 치료 또는 피부개선용 조성물
KR102292114B1 (ko) * 2020-11-13 2021-08-20 주식회사 피에프네이처 식물 복합 추출물을 유효성분으로 포함하는 피부 보습, 미세먼지 유발 염증 개선, 및 모공축소용 조성물
JPWO2023120233A1 (fr) * 2021-12-23 2023-06-29
KR102551642B1 (ko) * 2022-06-27 2023-07-11 주식회사 넥스텍인터내셔널 살리실산, 오레가노추출물, 오이풀추출물 및 월계수잎추출물을 함유하는 여드름성 피부 개선용 화장료 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923900A (en) 1985-01-24 1990-05-08 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
BE903646A (fr) * 1985-11-14 1986-05-14 Huysmans Guy A Composition pour le traitement et l'entretien de la peau
US4800197A (en) 1987-07-17 1989-01-24 Richardson-Vicks Inc. Anti-acne composition
WO1993021899A1 (fr) 1992-05-05 1993-11-11 The Procter & Gamble Company Composition de traitement de l'acne
US5242433A (en) * 1992-12-07 1993-09-07 Creative Products Resource Associates, Ltd. Packaging system with in-tandem applicator pads for topical drug delivery
US5470884A (en) * 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
US5958436A (en) * 1995-12-21 1999-09-28 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5753637A (en) * 1996-10-09 1998-05-19 Ideal Ideas, Inc. Method of treating acne conditions
US5910312A (en) * 1996-10-09 1999-06-08 Ideal Ideas, Inc. Acne treatment composition with vasoconstrictor
US5869062A (en) 1997-05-27 1999-02-09 Oliver; Benjamin Skin treatment composition
US6492326B1 (en) * 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
JP2002037736A (ja) * 2000-07-21 2002-02-06 Lion Corp ニキビ予防・治療剤
JP2002138033A (ja) 2000-10-30 2002-05-14 Shiseido Co Ltd 抗アクネ用皮膚外用剤
US6998372B2 (en) * 2001-08-16 2006-02-14 J&J Consumer Companies, Inc. Moisturizing detergent compositions
IL145751A (en) 2001-10-04 2010-12-30 Avi Dascalu Use of aluminum fluoride for the preparation of compositions for the treatment of acne vulgaris and folliculitis
EP1474170A1 (fr) * 2001-12-07 2004-11-10 Johnson & Johnson Consumer Companies, Inc. Procede pour reduire l'acne ou ameliorer le teint
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
US20040057921A1 (en) * 2002-09-23 2004-03-25 Walsh Star Marie Compositions for exfoliating skin and treating blackheads
US20040156873A1 (en) * 2003-02-10 2004-08-12 Gupta Shyam K. Topically Bioavailable Acne and Rosacea Treatment Compositions
US20040185022A1 (en) * 2003-02-19 2004-09-23 Steven Rubin Regimen for acne treatment
EP1449533A1 (fr) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Utilisation d'iode PVP pour le traitement de l'acné
US20060269504A1 (en) * 2003-04-15 2006-11-30 James Alexander G Use of alkyl resorcinols in the treatment of acne
US20050037034A1 (en) 2003-05-05 2005-02-17 Rhoades Dean L. Method, apparatus, and composition for treating acne
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
JP5388568B2 (ja) * 2005-03-30 2014-01-15 ルバンス セラピュティックス インク． ざ瘡を治療するための組成物及び方法

Also Published As

Publication number Publication date
US8580317B2 (en) 2013-11-12
BRPI0608951A2 (pt) 2010-02-17
EP1863507A4 (fr) 2012-01-04
US20070048234A1 (en) 2007-03-01
WO2006105450A2 (fr) 2006-10-05
JP2012184253A (ja) 2012-09-27
MX2007012101A (es) 2007-12-04
IL185540A0 (en) 2008-08-07
EP1863507A2 (fr) 2007-12-12
CA2600384C (fr) 2016-08-30
WO2006105450A3 (fr) 2006-12-14
JP5388568B2 (ja) 2014-01-15
JP2008534614A (ja) 2008-08-28
KR20080006568A (ko) 2008-01-16
US20100021571A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
CA2600384C (fr) Compositions et procede de traitement de l'acne
AU2016202140B2 (en) Compositions for skin exfoliation and use thereof
US20110129552A1 (en) Acne Treatment
CN111801108A (zh) 局部皮肤护理组合物
CN105209051A (zh) 痤疮溶液
KR20110074513A (ko) 피부 감염의 국소 치료법
JP2006525945A (ja) 皮膚を通して投薬される外用組成物
WO2009042402A2 (fr) Composition et procédé pour traiter l'acné rosacée
US11400071B2 (en) Hest G-18-0 and benzoyl peroxide compositions and methods for using the same
US20160184220A1 (en) Method for the Prevention and Treatment of Acne
US11877998B2 (en) Supplement composition
KR20240005769A (ko) 벤조일 퍼옥사이드 및 아젤라산을 포함하는 국소 제형, 및 이의 용도
EP2588095B1 (fr) Composition pour le traitement de l'acné simple
US20070207115A1 (en) Tea Tree Oil and Benzoyl Peroxide Acne Treatment
EP1752132A2 (fr) Compositions cosmétiques pour la peau
AU2006202906A1 (en) Compositions for use with skin
EP4615429A1 (fr) Compositions comprenant un ester phénéthylique de l'acide caféique (cape)
Aubin Acne: Put your best face forward
WO2006119540A1 (fr) Preparation destinee a traiter le psoriasis
Abdel-Naser et al. Rosacea and Related Diseases
ASSESSMENT Skin conditions
AU2006246350A1 (en) Preparation for treating psoriasis

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240903

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240903

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240903

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 19TH ANNIV.) - STANDARD

Year of fee payment: 19

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250206

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250206

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250206

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251110